Abstract In this paper, we describe the extraction of three alkaloids from the leaves and flowers of Erythrina speciosa, a plant documented in the literature to possess a range of potential medicinal applications. Two alkaloids were isolated from both leaves and flowers, with erythrartine being isolated from both plant parts. In agreement with the literature, we also isolated erysotrine from the flowers. The second alkaloid isolated from the leaves, and reported in this species for the first time, was (+)-11β-hydroxyerysotramidine.

Ten substituted pyrazolone derivatives were easily synthesized from perfluorinated allylic alcohols, via a straightforward two steps reaction involving a Heck-coupling/isomerization reaction and subsequent condensation of hydrazines. This fluorous supported methodology, that combines a cyclo-release approach and F-SPE purification allows for the obtaining of the final products with a good purity.

Melissa officinalis (L.) (Lamiaceae), a plant known as the lemon balm, is native to the east Mediterranean region and west Asia. Also found in tropical countries, such as Brazil, where it is popularly known as "erva-cidreira" or "melissa", it is widely used in aqueous- or alcoholic-extract form in the treatment of various disorders. The aim was to investigate in vivo its antigenotoxicity and antimutagenicity, as well as its genotoxic/mutagenic potential through comet and micronucleus assaying. CF-1 male mice were treated with ethanolic (Mo-EE) (250 or 500 mg/kg) or aqueous (Mo-AE) (100 mg/kg) solutions of an M. officinalis extract for 2 weeks, prior to treatment with saline or Methyl methanesulfonate (MMS) doses by intraperitoneal injection. Irrespective of the doses, no genotoxic or mutagenic effects were observed in blood and bone-marrow samples. Although Mo-EE exerted an antigenotoxic effect on the blood cells of mice treated with the alkylating agent (MMS) in all the doses, this was not so with Mo-AE. Micronucleus testing revealed the protector effect of Mo-EE, but only when administered at the highest dose. The implication that an ethanolic extract of M. officinalis has antigenotoxic/antimutagenic properties is an indication of its medicinal relevance.

A Química Combinatória (QC) é atualmente uma das mais promissoras ferramentas para a descoberta e o desenvolvimento de novas moléculas com potencialidades terapêuticas. Nesta metodologia de síntese os produtos são formados simultaneamente e podem ser testados biologicamente em uma só vez, seja em forma de misturas ou separadamente. A principal meta desta nova metodologia é reduzir o tempo necessário para a obtenção de um novo fármaco. A síntese de quimiotecas pode ser realizada através da utilização de polímeros insolúveis, solúveis ou pela tradicional síntese em solução, sendo que cada uma delas apresenta características que podem ser vantajosas ou não, dependendo da metodologia utilizada. O desenvolvimento de técnicas de high throughput screening (HTS) devido às suas características peculiares necessita de tempo, razão pela qual a síntese de quimiotecas pequenas e racionais é enfatizada.

Nowadays, Combinatorial Chemistry is one of the most promising tools used in the design and discovery of new molecules potentially useful in the therapeutics. In this methodology, the reaction products are synthesized simultaneously and can be evaluated once, either in a complex mixture or as isolated compounds. The main aim of this new approach is the time for the development of new drugs. The synthesis of combinatorial libraries can be performed using either insoluble or soluble polymers and also by the traditional organic synthesis in solution. Each one of these approaches presents features that may be advantageous depending on the final objective of the synthetic process. The development of high throughput screening (HTS) assays takes much time, which makes the synthesis of small and well designed combinatorial libraries the most recommended strategy.